Follow
Jurgen Vercauteren
Jurgen Vercauteren
assistant professor, statistician and lecturer at KU Leuven, BELGIUM
Verified email at kuleuven.be
Title
Cited by
Cited by
Year
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ...
The Lancet infectious diseases 19 (2), 143-155, 2019
3622019
Transmission of drug-resistant HIV-1 is stabilizing in Europe
J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ...
The Journal of infectious diseases 200 (10), 1503-1508, 2009
3102009
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
1872016
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10, 1-13, 2013
1862013
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
JT Maringwa, C Quinten, M King, J Ringash, D Osoba, C Coens, ...
Supportive Care in Cancer 19, 1753-1760, 2011
1782011
Relating increasing hantavirus incidences to the changing climate: the mast connection
J Clement, J Vercauteren, WW Verstraeten, G Ducoffre, JM Barrios, ...
International Journal of Health Geographics 8, 1-11, 2009
1592009
Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings
RZ Sangeda, F Mosha, M Prosperi, S Aboud, J Vercauteren, RJ Camacho, ...
BMC public health 14, 1-11, 2014
1142014
Algorithms for the interpretation of HIV-1 genotypic drug resistance information
J Vercauteren, AM Vandamme
Antiviral research 71 (2-3), 335-342, 2006
842006
Primary resistance to integrase strand-transfer inhibitors in Europe
M CasadellÓ, PM Van Ham, M Noguera-Julian, A vAn Kessel, C Pou, ...
Journal of antimicrobial chemotherapy 70 (10), 2885-2888, 2015
822015
CRF19_cpx is an evolutionary fit HIV-1 variant strongly associated with rapid progression to AIDS in Cuba
V Kouri, R Khouri, Y Alemßn, Y Abrahantes, J Vercauteren, ...
EBioMedicine 2 (3), 244-254, 2015
802015
Higher proportion of G2P [4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypicá…
J Matthijnssens, M Zeller, E Heylen, S De Coster, J Vercauteren, ...
Clinical Microbiology and Infection 20 (10), O702-O710, 2014
792014
Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania
F Mosha, V Muchunguzi, M Matee, RZ Sangeda, J Vercauteren, ...
BMC public health 13, 1-7, 2013
792013
Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, S Kirtley, ...
The Lancet HIV 7 (11), e772-e781, 2020
742020
Transmission of drug-resistant HIV-1 in Europe remains limited to single classes
A Wensing, J Vercauteren, D Van De Vijver, J Albert, B ┼sj÷, C Balotta, ...
Aids 22 (5), 625-635, 2008
712008
The global spread of HIV-1 subtype B epidemic
G Magiorkinis, K Angelis, I Mamais, A Katzourakis, A Hatzakis, J Albert, ...
Infection, genetics and evolution 46, 169-179, 2016
702016
Global dispersal pattern of HIV type 1 subtype CRF01_AE: a genetic trace of human mobility related to heterosexual sexual activities centralized in Southeast Asia
K Angelis, J Albert, I Mamais, G Magiorkinis, A Hatzakis, O Hamouda, ...
The Journal of infectious diseases 211 (11), 1735-1744, 2015
662015
Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment
MCF Prosperi, A Altmann, M Rosen-Zvi, E Aharoni, G Borgulya, F Bazso, ...
Antiviral therapy 14 (3), 433-442, 2009
652009
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal
J Vercauteren, K Deforche, K Theys, M Debruyne, LM Duque, S Peres, ...
Retrovirology 5, 1-8, 2008
652008
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
D Frentz, DAMC Van de Vijver, AB Abecasis, J Albert, O Hamouda, ...
BMC Infectious Diseases 14, 1-12, 2014
592014
Patterns of transmitted HIV drug resistance in Europe vary by risk group
D Frentz, D van de Vijver, A Abecasis, J Albert, O Hamouda, L J°rgensen, ...
PloS one 9 (4), e94495, 2014
542014
The system can't perform the operation now. Try again later.
Articles 1–20